BiotechTube
Home/CiVi Biopharma/Shal Jacobovitz
SJ

Shal Jacobovitz

Chief Executive Officer

CiVi Biopharma

Therapeutic Areas

CardiovascularMetabolicOrphan Diseases

CiVi Biopharma Pipeline

DrugIndicationPhase
CiVi 030Severe FrostbitePhase 3
CiVi 008Hypercholesterolemia and Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)Pre-clinical

Leadership Team at CiVi Biopharma

HØ
Henrik Ørum
Founder, Chief Scientific Officer
CS
Chuck Shear
Chief Development Officer
WB
Wade Benton
Chief Development Officer, Orphan Drugs
CF
Christopher Fuglesang
Chairman of the Board
View full CiVi Biopharma profile